KS

Kuldeep Singh

Director Director DIN 07668575
DIN 07668575 First appointment Jan 2017 Primary industry Agriculture
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Kuldeep Singh

Data last updated:

Kuldeep Singh was a Director at Jay Ambe Biotech Private Limited (2017) and Director at Kangra Enterprises Private Limited (2017–2020). The companies operate in Agriculture and Service.

DIN 07668575
Primary Designation Director
Industry Agriculture
First Appointment 06 Jan 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jay Ambe Biotech Private Limited U01110UP2017PTC088956
Director06 Jan 20172017₹26.9 Lakh (FY 2024)Active
Kangra Enterprises Private Limited U93090UP2017PTC099634
Director26 Dec 20172017₹1.6 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jay Ambe Biotech Private Limited
Kangra Enterprises Private Limited
Premium access

Shareholding and investment profile for Kuldeep Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kuldeep Singh

Kuldeep Singh was first appointed on 06 Jan 2017 as Director at Jay Ambe Biotech Private Limited.

Kuldeep Singh held 2 earlier board appointments: Jay Ambe Biotech Private Limited (Director, 06 Jan 2017 to 31 Dec 2017); Kangra Enterprises Private Limited (Director, 26 Dec 2017 to 10 Jan 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available